NORTH AMERICA AMNIOTIC MEMBRANE MARKET 2022-2028
MARKET OUTLOOK
Triton Market Research’s report alludes that the North American amniotic membrane market is assessed to attain a CAGR of 6.82% over the forecasting years 2022 to 2028. The United States and Canada form the market in the given region.
In Canada, an amniotic membrane has been used in treating wounds and burns. Since the amniotic membrane is rich in collagen, it has been useful in healing wounds effectively and reducing scars. Moreover, it has antibacterial properties, reducing pain significantly. The revival of amniotic membrane use in various treatments, including wound management, has occurred following the introduction of advanced techniques. In this regard, several techniques have been formed to desiccate the material while upholding several wound-healing attributes to produce a temperature-stable allograft. Therefore, such factors support the amniotic membrane market’s growth.
As per the US National Library of Medicine, the application of amniotic membrane has shown promising results in treating ocular surface disorders. Amniotic membrane transplantation has emerged as a key component of ocular surface reconstructions. Besides this, it has been used in treating limbal stem cell deficiency (LSCD) to protect limbal stem cells. Amniotic membrane use in burn injuries is also witnessed in the country. Such developments are expected to boost the amniotic membrane market on a progressive path.
COMPETITIVE OUTLOOK
The major companies in the amniotic membrane market consist of Labtician Ophthalmics Inc, Human Regenerative Technologies, Organogenesis, and Sky Biologics LLC.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook